Adaptive Biotechnologies Corporation ADPT

Set alert

Price alert · ADPT

All alert types
26.15 USD +1.09 +4.35%

As of Nov 3, 11:47 AM ET

Bid
26.12 × 4
Ask
26.17 × 4
25.33 Day range 26.46
12.00 52-week range 30.74
YTD
+61.02%
1 year
+50.81%
Open
25.46
Prev close
25.06
Mkt cap
4.17B
Vol
383.29K
Avg vol
2.17M
EPS
-0.41
P/E
0.00
Div yield
0.00%
More statistics
Low
25.33
High
26.46
Forward P/E
-139.00
Beta
2.15
Short ratio
4.56
Inst. own
99.03%
Dividend
0.00
Ex-div date
Earnings
Nov 4, 2026
50-d avg
26.38
200-d avg
19.60
1y target
30.21

3M chart

Chart tools
Interval

Events in this range
  • Aug 4, 2026Rating: Piper Sandler · Overweight → Overweight
  • Sep 22, 2026Rating: BTIG · Buy → Buy
  • Sep 29, 2026Rating: Goldman Sachs · — → Buy
  • Oct 1, 2026Rating: Guggenheim · Buy → Buy
  • Oct 13, 2026Rating: Morgan Stanley · Equal-Weight → Equal-Weight
  • Oct 13, 2026Rating: TD Cowen · Buy → Buy
Signals (20)
NameDateAgo
SMA: BearishNov 2, 20261 day ago
SMA: BearishOct 30, 20264 days ago
SMA: BullishOct 27, 20261 week ago
MACD: Buy SignalOct 27, 20261 week ago
SMA: BullishOct 26, 20261 week ago
SMA: BearishOct 12, 20263 weeks ago
SMA: BearishOct 7, 20263 weeks ago
MACD: Sell SignalOct 6, 20264 weeks ago
MACD: Buy SignalOct 5, 20264 weeks ago
MACD: Sell SignalOct 1, 20261 month ago
RSI: OverboughtSep 24, 20261 month ago
MACD: Buy SignalSep 16, 20261 month ago
RSI: OverboughtSep 16, 20261 month ago
SMA: BullishSep 15, 20261 month ago
SMA: BullishSep 2, 20262 months ago
SMA: BearishSep 1, 20262 months ago
MACD: Sell SignalAug 14, 20262 months ago
MACD: Buy SignalAug 7, 20262 months ago
MACD: Sell SignalAug 6, 20262 months ago
MACD: Buy SignalAug 5, 20263 months ago

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 30.21 +15.5% upside
Target (low)
21.00
Target (mean)
30.21
Target (high)
35.00
Ratings (0m) 8 8 buy · 0 hold · 0 sell
  • Strong buy2
  • Buy6
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 8
  • 1 month ago 9
  • 2 months ago 8

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

ADPT analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.09552-0.11 – -0.080.06-259.2%71.60M-23.8%7
Next quarter-0.06409-0.08 – -0.04-0.09+28.8%79.29M+10.6%7
Current year-0.54243-0.57 – -0.51-0.39-39.1%293.25M+5.9%7
Next year-0.18029-0.32 – -0.01-0.54243+66.8%360.14M+22.8%7

Upgrades and downgrades

The latest rating changes

ADPT analyst upgrades and downgrades
DateFirmActionFromTo
Oct 13, 2026TD CowenMaintainedBuyBuy
Oct 13, 2026Morgan StanleyMaintainedEqual-WeightEqual-Weight
Oct 1, 2026GuggenheimMaintainedBuyBuy
Sep 29, 2026Goldman SachsInitiated—Buy
Sep 22, 2026BTIGMaintainedBuyBuy
Aug 4, 2026Piper SandlerMaintainedOverweightOverweight
Jul 30, 2026Morgan StanleyMaintainedEqual-WeightEqual-Weight
Jul 30, 2026TD CowenMaintainedBuyBuy
Jul 30, 2026GuggenheimMaintainedBuyBuy
Jul 30, 2026BTIGMaintainedBuyBuy
Jul 9, 2026Morgan StanleyMaintainedEqual-WeightEqual-Weight
Jun 29, 2026GuggenheimMaintainedBuyBuy
Jun 17, 2026BTIGReiteratedBuyBuy
May 12, 2026Morgan StanleyMaintainedEqual-WeightEqual-Weight
May 6, 2026JP MorganMaintainedOverweightOverweight
May 6, 2026TD CowenMaintainedBuyBuy
May 6, 2026GuggenheimReiteratedBuyBuy
May 6, 2026BTIGReiteratedBuyBuy
Feb 6, 2026JP MorganMaintainedOverweightOverweight
Feb 6, 2026BTIGMaintainedBuyBuy
Jan 26, 2026GuggenheimMaintainedBuyBuy
Nov 11, 2025Morgan StanleyMaintainedEqual-WeightEqual-Weight
Nov 6, 2025JP MorganMaintainedOverweightOverweight
Nov 6, 2025BTIGMaintainedBuyBuy
Oct 22, 2025BTIGMaintainedBuyBuy
Oct 15, 2025Piper SandlerMaintainedOverweightOverweight
Oct 13, 2025JP MorganMaintainedOverweightOverweight
Sep 30, 2025GuggenheimInitiated—Buy
Aug 6, 2025JP MorganMaintainedOverweightOverweight
Aug 6, 2025TD CowenMaintainedBuyBuy